20 hours ago
1
Stock to Buy: Shares of Aurobindo Pharma Ltd (NSE: AUROPHARMA) edged 0.35 per cent lower to Rs 1,154.00 in morning trade on Thursday, tracking weak market sentiment amid global tariff worries. Despite the marginal decline, market expert Anil Singhvi has named Aurobindo Pharma his ‘Stock of the Day’, recommending investors to adopt a buy-on-dips strategy.
Anil Singhvi sees strong technical support at Rs 1,135, with an upside target of Rs 1,180. He believes the stock could face short-term pressure from US tariff-related developments but sees long-term value after the company’s recent acquisition.
“Aurobindo’s $250 million acquisition of a US-based company is a game-changer,” said Singhvi on Zee Business. “It strengthens their global presence and offers long-term growth opportunities. Any dip should be seen as a buying opportunity.”
Key Drivers:
Robust Acquisition Play: The company recently announced a $250 million acquisition of a US pharma firm, expanding its presence in regulated markets.
Technical Outlook: Support at Rs 1,135; resistance near Rs 1,180.
Sector Tailwinds: Pharma stocks are finding favour amid global uncertainty and defensive rotation.
Market Snapshot:
Aurobindo Pharma share price today: Rs 1,154.00 (−0.35%)
Nifty Pharma Index: Trading 0.96 per cent lower as of 11:13 AM.
Investor Strategy: Accumulate on weakness, watch for breakout above Rs 1,180
English (US) ·